BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29929476)

  • 1. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
    BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
    Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
    Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
    Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
    PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection.
    Li BS; Zhao YL; Guo G; Li W; Zhu ED; Luo X; Mao XH; Zou QM; Yu PW; Zuo QF; Li N; Tang B; Liu KY; Xiao B
    PLoS One; 2012; 7(7):e41629. PubMed ID: 22860003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
    Zhu C; Ren C; Han J; Ding Y; Du J; Dai N; Dai J; Ma H; Hu Z; Shen H; Xu Y; Jin G
    Br J Cancer; 2014 Apr; 110(9):2291-9. PubMed ID: 24595006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs in plasma of patients with gastric cancers.
    Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
    Emami SS; Nekouian R; Akbari A; Faraji A; Abbasi V; Agah S
    J Cancer Res Ther; 2019; 15(1):115-119. PubMed ID: 30880765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.
    Li F; Guo Y; Liu J; Zhang R
    PLoS One; 2017; 12(5):e0178427. PubMed ID: 28562634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
    Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
    Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
    Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
    Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
    Jiang L; Li X; Cheng Q; Zhang BH
    Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA expression profile as a diagnostic panel for gastric cancer.
    Huang S; Wang J; Li J; Luo Q; Zhao M; Zheng L; Dong X; Chen C; Che Y; Liu P; Qi J; Huang C
    Jpn J Clin Oncol; 2016 Sep; 46(9):811-8. PubMed ID: 27380811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer.
    Cheng J; Yang A; Cheng S; Feng L; Wu X; Lu X; Zu M; Cui J; Yu H; Zou L
    Med Sci Monit; 2020 Jun; 26():e923444. PubMed ID: 32487978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
    Valladares-Ayerbes M; Reboredo M; Medina-Villaamil V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Haz M; Santamarina I; Blanco M; Fernández-Tajes J; Quindós M; Carral A; Figueroa A; Antón-Aparicio LM; Calvo L
    J Transl Med; 2012 Sep; 10():186. PubMed ID: 22954417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
    Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
    Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B
    Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
    Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
    Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.